BIOLASE Inc  

(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for biol
2.49
+0.01 (0.40%)
Sep 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.45 - 2.52
52 week 1.47 - 3.53
Open 2.49
Vol / Avg. 54,162.00/203,947.00
Mkt cap 109.31M
P/E     -
Div/yield     -
EPS -0.50
Shares 43.89M
Beta 2.59
Inst. own 38%
Aug 27, 2014
BIOLASE Inc Annual Shareholders Meeting
Aug 7, 2014
Q2 2014 BIOLASE Inc Earnings Call
Aug 7, 2014
Q2 2014 BIOLASE Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -63.21% -20.35%
Operating margin -60.79% -19.49%
EBITD margin - -17.98%
Return on average assets -93.82% -36.44%
Return on average equity -433.77% -113.26%
Employees 220 -
CDP Score - -

Address

4 CROMWELL
IRVINE, CA 92618
United States - Map
+1-949-3611200 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BIOLASE, Inc., formerly BIOLASE Technology, Inc. is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications in a minimally invasive manner. The Company also manufactures and sells disposable products and accessories for its laser systems. The Company's Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed. The Company also markets flexible fibers and hands pieces. For the Company's ezlase system, the Company sells tooth whitening gel kits. In April 2012, it purchased 159 Waterlase MD Turbo laser systems from Henry Schein, Inc.

Officers and directors

Paul N. Clark Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Frederick D. Furry Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Alexander K Arrow M.D. Chief Medical Officer
Age: 44
Bio & Compensation  - Reuters
Jeffrey M. Nugent President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 58
Bio & Compensation  - Reuters
Tamar D. Howson Director
Age: 65
Bio & Compensation  - Reuters
Terence A. Kelly Ph.D. Director
Bio & Compensation  - Reuters
Jonathan T. Lord M.D. Director
Age: 59
Bio & Compensation  - Reuters
Frederic H. Moll M.D. Director
Age: 60
Bio & Compensation  - Reuters